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Abstract
Introduction: The aim of the study was to investigate the state-of-the-art of the performance of critical value reporting and provide recommenda-
tions for laboratories setting critical value reporting time frames.  
Materials and methods: The National Centre for Clinical Laboratories in China initiated a critical value reporting investigation in 2015. A questi-
onnaire related to critical value reporting policy was sent to 1589 clinical laboratories in China online. The questionnaire consisted of a set of que-
stions related to critical value reporting policy and a set of questions related to timeliness of critical value reporting. The survey data were collected 
between March and April 2015.
Results: A total survey response rate was 61.2%. The critical value unreported rate, unreported timely rate, and clinical unacknowledged rate of 
more than half of participants were all 0.0%. More than 75.0% of participants could report half of critical values to clinicians within 20 minutes 
and could report 90.0% of critical values to clinicians within 25 minutes (from result validation to result communication to the clinician). The medi-
an of target critical value reporting time was 15 minutes. “Reporting omission caused by laboratory staff”, “communications equipment failure to 
connect”, and “uncompleted application form without contact information of clinician” were the three major reasons for unreported critical value.
Conclusions: The majority of laboratories can report critical values to responsible clinical staff within 25 minutes. Thus, this value could be re-
commended as suitable critical value reporting time frame for biochemistry laboratories in China. However, careful monitoring of the complete 
reporting process and improvement of information systems should ensure further improvement of critical value reporting timeliness.
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The term “critical result” was first proposed by Dr. 
George D. Lundberg over 40 years ago. He sug-
gested that patients with critical test results were 
in a life-threatening situation if action was not tak-
en quickly, thus critical results should be commu-
nicated to responsible caregivers without delay (1). 
As timely release and reporting of critical results is 
essential for optimal clinical care, critical results’ re-
porting has drawn great attention. It has not only 
become a laboratory accreditation requirement, 
but also a quality practice to improve service qual-
ity in the clinical laboratory (2,3). 
The International Standardization Organization 
(ISO) 15189 specified the requirement on timeli-
ness of critical values reporting (2). The National 
Patients Safety Goals in China, Hospital Manage-
ment Evaluation Guideline, and the Evaluation 
Standards for General Hospitals also addressed the 
importance of timeliness reporting of critical val-
ues (4). Although timeliness of critical value report-
ing has been specified, none of them described 
the time frames of critical value reporting in detail. 
The Clinical and Laboratory Standards Institute 
(CLSI) document GP47 recommended that “imme-
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diately life-threatening, critical-risk results should 
be reported within one hour of identification or 
availability of the result” (5). It is obviously inap-
propriate to use recommendation of one hour 
without verification. Besides, quality specifications 
can be set based on the “state-of-the-art” (6). 
Based on a College of American Pathologists (CAP) 
Q-Probes study, a laboratory goal of reporting crit-
ical results within 15 to 30 minutes after testing is 
complete were proposed for inpatient settings (7). 
The aim of the study was to investigate the current 
performance of critical value reporting in clinical 
laboratories in China. Accordingly, suggestions on 
good quality practices of critical value reporting 




The National Centre for Clinical Laboratories 
(NCCL) in China initiated a cross-sectional survey 
about critical value reporting performance. It 
started in March and ended in April of 2015. A 
questionnaire related to critical value reporting 
policy was sent to 1589 clinical laboratories in Chi-
na online. Participants of the survey were labora-
tories that participate in routine chemistry exter-
nal quality assessment (EQA) programs organized 
by NCCL. Most of the laboratories operate within 
Class 3A hospitals (first-class hospitals with more 
hospital beds and higher medical quality in China), 
followed by Class 3B hospitals, Class 2 and primary 
hospitals. Clinical laboratories from general hospi-
tals were also included while independent com-
mercial laboratories were excluded, as these might 
apply a completely different critical value report-
ing policy. The survey data were collected be-
tween March and April 2015.
The questionnaire consisted of two parts. The first 
part included the demographic data of participat-
ing laboratories and critical value reporting poli-
cies adopted. The demographic data of participat-
ing laboratories included hospital grade and num-
ber of hospital beds, laboratory accrediting infor-
mation and data on laboratory information system 
(LIS) used. The data on critical value reporting pol-
icy included repeated testing, recording, and re-
porting of critical values. Using computer systems 
to report critical values refers to the use of LIS and 
hospital information systems (HIS) to report critical 
values. In order to compare the performance of 
laboratories of different grade and laboratories 
pertaining to hospitals with different bed num-
bers, laboratories were divided into several sub-
groups. Subgroups included: a) laboratories from 
Class 3A hospital, Class 3B hospital, and, Class 2 or 
primary hospital; b) laboratories pertaining to hos-
pitals of 0 to 1000, 1001 to 2000, and, more than 
2001 beds; and c) ISO 15189 or CAP accredited lab-
oratories and the non-accredited ones. 
The second part of the questionnaire aimed to col-
lect information on timeliness of critical value re-
porting for inpatient, outpatient and emergency 
(STAT) patient in each laboratory during one 
month. This included the number failures to notify 
critical values, number of critical values notified af-
ter a consensually agreed time (from result valida-
tion to result communication to the clinician), 
number of failures to obtain receipt acknowledge-
ment from clinicians after critical value notifica-
tion, median and 90th percentiles (P90) of time 
from result validation to result communication 
and total number of critical values communicated 
over the same period. 
Data collected in the second part of questionnaire 
was used to calculate quality indicators (QIs) based 
on formulas presented in Table 1. Five QIs were in-
cluded: a) critical value unreported rate; b) critical 
value unreported timely rate; c) critical value clini-
cal unacknowledged rate; d) median of critical val-
ue reporting time; and e) P90 of critical value re-
porting time (from result validation to result com-
munication to the clinician). The reasons for unre-
ported critical values and the target critical value 
reporting time were also collected. Invitation, pri-
mary coverage and submission path of this investi-
gation were notified via short messages and paper 
letters to the laboratory leaders or quality manag-
ers. They were also asked to read instructions 
about data collection and questionnaire fulfilling 
online before uploading. Laboratories were ad-
vised to collect related data with the use of LIS and 
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HIS. Those that did not have LIS or HIS collected 
related data by accessing to related records manu-
ally. Laboratory leaders or quality managers were 
asked to upload related data via online EQA plat-
form for critical value reporting investigation de-
veloped by the NCCL within 2 month after receiv-
ing it voluntarily (6,8,9). 
Statistical analysis
EXCEL (Microsoft, Redmond, WA) (2007 version) 
and SPSS 13.0 (SPSS Inc., Chicago, USA) were used 
to analyse the data collected. Normality was test-
ed for all variables by Kolmogorov-Smirnov test 
and the distribution results were expressed as the 
5th (P5), 25th (P25), 50th (P50), 75th (P75) and the 
95th percentiles (P95). 
Error rates values were calculated for critical value 
unreported rate; critical value unreported timely 
rate; and critical value clinical unacknowledged 
rate. Calculation formulas of error rates are shown 
in Table 1. Results on the error rates were ex-
pressed as percentages. In order to evaluate per-
formance on critical value reporting, six sigma was 
calculated by use of an on line sigma calculator 
(10). Six-sigma represents a word-class quality with 
99.9997% of the products free of defects, while 
3-sigma means the performance of the procedure 
is 93.3193% perfect and sigma values < 3 sigma 
were not acceptable (11).
To test the differences between different sub-
groups of patients and hospitals, Kruskal-Wallis 
and Mann-Whitney U rank sum tests were used. 
Kruskal-Wallis rank sum test was used to obtain 
differences among 3 subgroups of data, whereas 
Mann-Whitney U rank sum test was used to obtain 
the difference between two subgroups of data. P 
≤ 0.05 was chosen as the threshold of significance. 
If significant differences (P ≤ 0.05) were detected 
by Kruskal-Wallis rank sum test, Mann-Whitney U 
rank sum test was employed to find out the data 
of which two subgroups were significant different, 
under this circumstances P ≤ 0.017 was chosen as 
the threshold of significance. 
Results
A total of 973 laboratories submitted fulfilled ques-
tionnaires online. The response rate was 61.2% 
(973/1589). The demographic data of participating 
laboratories and their critical value reporting poli-
cies are presented in Table 2.
Quality indicators
Results on the error rates, sigma values (σ), and re-
porting time for the QIs and target critical value re-
porting time included in the survey are shown in 
Table 3. The critical value unreported rate, unre-
ported timely rate, and reporting clinical unac-
Quality indicator Calculation formula used to obtain  the quality indicator
•	 Critical value unreported rate Number of failures to notify critical values divided by total number of critical values communicated over the same period.
•	 Critical value unreported 
timely rate
Number of critical values notified after a consensually agreed time (from result validation to 
result communication to the clinician) divided by total number of critical values communicated 
over the same period. 
•	 Critical value clinical 
unacknowledged rate
Number of failure to obtain receipt acknowledgement from clinicians after critical value 
notification divided by total number of critical value notified.
•	 Median of critical value 
reporting time
Median of time from result validation to result communication to the clinician.
•	 P90 of critical value reporting 
time
P90 of time from result validation to result communication to the clinician.
The indicators were calculated for each laboratory from corresponding data provided by each laboratory. P90 - 90th percentile.
Table 1. Quality indicators and corresponding calculation formulas included in the national survey
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Questions and possible answers Number of laboratories (%)
1.Which grade does your hospital belong to?
A. Class 3A hospital 592 (60.8)
B. Class 3B hospital 179 (18.4)
C. Class 2 or primary hospital 202 (20.8)
2. How many beds does your hospital occupy?
A. 0 - 1000 551 (56.6)
B. 1001 - 2000 316 (32.5)
C. More than 2001 106 (10.9)
3. Is your laboratory accredited according to ISO 15189 or CAP?
A. Yes 102 (10.5)
B. No 871 (89.5)
4. Is a laboratory information system applied in your laboratory?
A. Yes 953 (98.0)
B. No 20 (2.1)
5. Has a critical value reporting policy been established in your laboratory?
A. Yes 961 (98.8)
B. No 12 (1.2)
6. Is repeated testing performed before calling a critical value in your laboratory?
A. Yes 922 (94.8)
B. No 51 (5.2)
7. If the repeated result is not significantly different, which value is reported?
A. First result 633 (68.7)
B. Second result 147 (15.9)
C. Average of results 107 (11.6)
D. Others 35 (3.8)
8. If the repeated result is not significantly different but no longer classified as a critical value, is the critical value still 
reported?
A. Yes 374 (40.6)
B. No 548 (59.4)
9. If the repeated result is significantly different but no longer classified as a critical value, is the critical value still 
reported to the clinician?
A. Yes 48 (5.2)
B. No 91 (9.9)
C. It depends on the third repeated result 783 (84.9)
10. Is a critical value reporting document mandatory in your laboratory?
A. Yes 958 (98.5)
B. No 15 (1.5)
11. How do you record critical value reporting in your laboratory?
A. Computer system 122 (12.7)
B. Paper recording 293 (30.6)
C. Both A and B 543 (56.7)
Table 2. Questions and answers of national survey on critical value reporting in China
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Questions and possible answers Number of laboratories (%)
12. Which items are included in critical value reporting documents in your laboratory*?
A. Patient’s name 956 (99.8)
B. Patient’s ID 735 (76.7)
C. Patient’s ward and bed number 778 (81.2)
D. Examination and result that was reported 942 (98.3)
E. Person who received the report of the result 913 (95.3)
F. Person in the laboratory who reported the result 860 (89.8)
G. Time the result was verified and available for call–back 518 (54.1)
H. Time the result was reported 862 (90.0)
I. Verification that the verbal report was recorded accurately by the recipient (read-back) 518 (54.1)
13. How do you report critical values*?
A. Phone calls 932 (95.8)
B. SMS 92 (9.5)
C. Computer system† 525 (54.0)
14. Were rapid changes in laboratory results included in critical list in your laboratory?
A. Yes 239 (24.6)
B. No 734 (75.4)
ISO - international organization for standardization. CAP - College of American Pathologists. ID – identification. SMS - Short 
Message Service (critical values reported through sending short text messages to responsible caregivers). *More than one answer 
to the question could be provided. † Refers to the use of laboratory information systems and hospital information systems to 
report critical values.
Table 2. Continued.
knowledged rate of more than half of laboratories 
were 0 (6σ). However, there still were nearly 5.0% 
of laboratories showing unacceptable perfor-
mance with σ values below 3 (Table 3). More than 
75.0% of participants could report half of critical 
values to clinicians within 20 minutes and 90% of 
critical values to clinicians within 25 minutes (Table 
3). 
Comparison of different groups
Significant differences were detected between 
laboratories occupying different bed number for 
critical value unreported rate of stat patient and 
critical value unreported timely rate, as shown in 
Table 4. There were no significant differences be-
tween QIs reported by laboratories from different 
hospital grade, and ISO 15189 or CAP accredited 
laboratories and the non-accrediting ones (P > 
0.05). 
Reasons for unreported critical value
Reasons submitted by participants for unreported 
critical value among outpatient, inpatient and stat 
patient are shown in Table 5.
Discussion
Timeliness and accuracy of critical value reporting 
are important aspects that should be ensured in 
clinical laboratories. The National Patients Safety 
Goals in China in 2007, Hospital Management Eval-
uation Guideline, as well as the Evaluation Stand-
ards for General Hospitals all required the timeli-
ness reporting of critical values (4). Majority of par-
ticipants in this survey were from Class 3 hospitals 
in China. In order to fulfil these national require-
ments, great attention has been drawn to critical 
values reporting policies. Based on this situation, 
the critical value unreported rate, unreported 
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P5 P25 P50 P75 P95
Quality indicators included in the survey
Critical value unreported rate
Inpatient 918 0.0 (3.0) 0.0 (6.0) 0.0 (6.0) 0.0 (6.0) 6.7 (6.0)
0.002
0.002‡
Outpatient 635 0.0 (3.0) 0.0 (6.0) 0.0 (6.0) 0.0 (6.0) 6.3 (6.0) 0.284§
Stat patient 645 0.0 (2.9) 0.0 (6.0) 0.0 (6.0) 0.0 (6.0) 7.6 (6.0) 0.043||
Critical value unreported timely rate
Inpatient 792 0.0 (2.3) 0.0 (6.0) 0.0 (6.0) 3.0 (6.0) 22.7 (6.0)
< 0.001
< 0.001‡
Outpatient 543 0.0 (2.3) 0.0 (6.0) 0.0 (6.0) 0.0 (6.0) 20.2 (6.0) 0.414§
Stat patient 572 0.0 (2.4) 0.0 (3.4) 0.0 (6.0) 0.0 (6.0) 17.4 (6.0) < 0.001||
Critical value reporting clinical unacknowledged rate
Inpatient 877 0.0 (2.2) 0.0 (6.0) 0.0 (6.0) 0.0 (6.0) 25.8 (6.0)
< 0.001
< 0.001‡
Outpatient 603 0.0 (2.3) 0.0 (6.0) 0.0 (6.0) 0.0 (6.0) 20.5 (6.0) 0.442§
Stat patient 604 0.0 (2.9) 0.0 (6.0) 0.0 (6.0) 0.0 (6.0) 18.5 (6.0) < 0.001||
Median of critical value reporting time in minutes
Inpatient 686 1.0 5.0 10.0 20.0 60.0
0.004
0.011‡
Outpatient 641 0.0 4.0 8.0 18.0 60.0 0.656§
Stat patient 627 0.0 4.0 8.0 15.0 54.2 0.002||
P90 of critical value reporting time in minutes
Inpatient 678 1.0 7.0 12.0 25.0 85.1
0.004
0.008‡
Outpatient 610 0.0 5.0 10.0 24.0 81.8 0.804§
Stat patient 623 0.0 5.0 10.0 22.0 61.8 0.003||
Target critical value reporting time
Inpatient 901 5.0 10.0 15.0 30.0 90.0
0.695 -Outpatient 641 5.0 10.0 15.0 30.0 90.0
Stat patient 643 5.0 10.0 15.0 30.0 60.0
Error rates are presented as percentages with accompanying sigma values in parenthesis. Error rates were calculated according 
to formulas in Table 1, whereas sigma values were calculated using calculations provided in Reference 10. P5 - 5th percentile. P25 
- 25th percentile. P50 - 50th percentile. P75 - 75th percentile. P90 - 90th percentile. P95 - 95th percentile. *Kruskal-Wallis rank sum 
test was used to test the differences between inpatients, outpatients and stat patients with a threshold of significance of P ≤ 
0.05. †Mann-Whitney U rank sum test was used to test the differences between two groups with a threshold of significance of P ≤ 
0.017. ‡Differences between inpatient and outpatient were tested. §Differences between outpatient and stat patient were tested. 
||Differences between stat patient and inpatient were tested.
Table 3. Results on the error rates, sigma values, reporting time for quality indicators along with target critical value reporting time 
obtained among different category of patients in the national survey of critical value reporting
timely rate, and clinical unacknowledged rate of 
more than half of participants were satisfying with 
zero error rates. More than 75.0% of participants 
could report half of critical values to clinicians 
within 20 minutes and could report 90% of critical 
values to clinicians within 25 minutes.
A CAP Q-Probes study of 121 institutions showed 
that laboratories needed a median of 5 minutes for 
staff to notify critical values from result available to 
reporting complete, calling critical results within 15 
to 30 minutes after completed testing. This period 
was proposed as target timeframe for inpatient set-
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P5 P25 P50 P75 P95
Critical value unreported rate
Stat patient
0-1000 354 0.0 0.0 0.0 0.0 2.8
0.001
< 0.001‡
1001-2000 222 0.0 0.0 0.0 0.0 18.0 0.304§
> 2001 69 0.0 0.0 0.0 0.0 12.0 0.200||
Critical value unreported timely rate
Inpatient
0-1000 450 0.0 0.0 0.0 2.3 19.6
< 0.001
0.003‡
1001-2000 256 0.0 0.0 0.0 5.0 23.0 0.173§





0-1000 299 0.0 0.0 0.0 14.2
0.001
0.001‡
1001-2000 187 0.0 0.0 0.0 28.7 0.577§
> 2001 57 0.0 0.0 0.0 4.7 34.3 0.004||
Stat patient
0-1000 308 0.0 0.0 0.0 5.9 15.6
0.001
0.002‡
1001-2000 205 0.0 0.0 0.0 2.4 20.7 0.377§
> 2001 59 0.0 0.0 0.0 6.5 30.7 0.003||
Only quality indicators with Kruskal-Wallis rank sum test P value ≤ 0.05 are presented. The error rates are presented as percentages. 
P5 - 5th percentile. P25 - 25th percentile. P50 - 50th percentile. P75 - 75th percentile. P90 - 90th percentile. P95 - 95th percentile. 
*Kruskal-Wallis rank sum test was used to test the differences among hospitals occupying 0 -1000, 1001-2000 and more than 2001 
beds; P ≤ 0.05 was chosen as the threshold of significance. †Mann-Whitney U rank sum test was used to test the differences between 
two groups, P ≤ 0.017 was chosen as the threshold of significance. ‡Differences between hospitals with 0-1000 and 1001-2000 beds 
were tested. §Differences between hospitals with 1001-2000 and > 2001 beds were tested. ||Differences between hospitals with > 
2001 beds and 0-1000 beds were tested.
Reason for unreported critical value
Occurrence (N)
Inpatient Outpatient Stat patient
Reporting omission caused by laboratory staff 111 32 49
Communications equipment failure to connect 104 51 37
Uncompleted application form without contact information of clinician 82 66 44
Uncompleted application form without contact information of outpatient 0 11 0
Table 4. Critical value unreported rate and critical value unreported timely rates among different category of patients admitted to 
laboratories in different hospitals participating in the national survey of critical value reporting 
Table 5. Reasons for unreported critical value submitted by participants in the national survey of critical value reporting
ting in the same survey (7). Recommendations of 
communicating critical test results proposed by 
Massachusetts Hospitals also give suggestions on 
critical value reporting time frames. They believe 
notification time parameters for communicating 
critical test results should be designed according to 
urgency, e.g. within 1 hour, within the shift (target 
6-8 hours), within 3 days (12). As more than 75.0% of 
participants in our survey could report 90.0% of 
critical values to clinicians within 25 minutes, 25 
minutes (from result validation to result communi-
cation to the clinician) was recommended as a tar-
get time to encourage improvements in the rest of 
the laboratories investigated. However, authors be-
lieve laboratories should set their target critical val-
ue reporting timeframes with clinicians in their in-
stitutions to fulfil clinical need, 25 minutes was only 
a reference.
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A CAP Q-Track study assessed the frequency of un-
reported critical values in 180 institutions with dif-
ferent size and scope. The median rates of com-
munication failure (critical values without docu-
mented report to a responsible caregiver) were 
higher for outpatients than inpatients (13). Other 
studies also indicated that the biggest obstacle to 
successful critical value reporting was outpatient 
physician not returning calls or pagers (14). On the 
contrary, data in this survey showed that critical 
value unreported rate of inpatients were signifi-
cantly higher than that of outpatients; similar re-
sults were obtained for critical value unreported 
timely rate and clinical unacknowledged rate. Fur-
thermore, the critical value reporting time of inpa-
tients was significant longer than for outpatients. 
Low critical value incidence with less reporting 
workload for outpatient may partly explain this re-
sult. Significant differences for critical value report-
ing performance were detected between labora-
tories pertaining to hospitals with different bed 
numbers. Laboratories in hospitals with less bed 
numbers seemed to have better performances 
than laboratories in hospitals with more beds. 
Heavy workload in large hospital may also be re-
lated. On one hand, laboratory staff in laboratories 
with heavy workload is always busy with testing 
patients’ specimens and this may delay the report-
ing of critical values they detected. On the other 
hand, it may be a more difficult task to contact 
busy responsible caregivers in large hospitals than 
in small ones. Call centres with dedicated staff to 
report critical values or electronic communica-
tions systems were recommended in laboratories 
with larger workload (5).
“Reporting omission caused by laboratory staff”, 
“communications equipment failure to connect”, 
and “uncompleted application form without con-
tact information of clinician” were the three major 
reasons for unreported critical values. Training ac-
tivities are needed for laboratory staff to realize 
the importance of timely and accurate reporting 
of critical values in case of staff omissions. A back-
up plan for LIS shutdown and complete applica-
tion information in HIS are also needed to avoid 
unreported critical values caused by “communica-
tions equipment failure to connect” and “uncom-
pleted application form without contact informa-
tion of clinician”.
The majority of laboratories repeat critical value 
tests before reporting to responsible caregivers. 
Munoz evaluated the efficacy of repeating critical 
values in the United States, and found that 68.2% 
of laboratories always repeat critical results before 
reporting (15). In a CAP Q-Probes study, 48 out of 
86 laboratories always repeated chemistry critical 
values before reporting (16). In this survey, most 
(94.8%) of participants implemented this practice 
in their laboratory as well. However, this practice 
was generally established to assure accuracy of 
critical results when manual methods were domi-
nant while laboratory automation and standardi-
zation were not prevalent (17). Laboratory may re-
peat examinations of such critical values before 
verification to avoid analysis errors. However now-
adays several research groups have determined 
that automated critical values are accurate using 
modern equipment and methods, and that re-
peated examinations caused significant delays in 
reporting (18,19). Critical values obtained with 
modern instrumentation are likely to be valid 
when they fall within the reportable range of the 
analyzer and do not fail delta check rules (5). This 
practice may cause reporting delays without sig-
nificant benefit and it should be carefully evaluat-
ed for its usefulness before being implemented. 
Although electronic patient records, LIS and HIS 
have been introduced in hospitals widely, the 
most common reporting system is still telephone 
communication with the recipient expected to 
verify accuracy by documenting and reading back 
the report. It is worth noting that more than half of 
participants have employed computer system (LIS 
and HIS) to report critical value. Evidence showed 
that digital, non-telephonic systems seemed to be 
timelier and more accurate compared to tele-
phone communication (20-22). However, the re-
ceipt of critical value by responsible caregivers 
should be assured and documented if digital sys-
tems are used to replace telephone.
Only 24.6% of participants included rapid chang-
ing results in their critical lists. As these results may 
also indicate life-threatening situations, laborato-
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ries should pay more attention to avoid neglecting 
these situations when only critical limits are em-
ployed. Therefore, laboratories were advised to set 
multiple rules in critical value list and import them 
in LIS to help identifying rapid change of test re-
sults that may indicate life-threatening situations. 
Nowadays, there were many common terms used 
in different literature including “critical result”, 
“critical value”, “panic value”, “crisis value” and 
“alarm value” (14,23). The CLSI document GP47 
uses the term “critical-risk result” rather than “criti-
cal value” in order to emphasize the focus on the 
risk level to patients, rather than the degree of the 
result abnormality (5,24). As only quantitative 
items were included in this survey meanwhile “crit-
ical value” was widely used in China, “critical val-
ue” was employed here. 
Although critical value reporting policies has been 
investigated before (4), there was not any investi-
gation on the timeliness of critical value reporting 
in different laboratories ever launched in China. 
This investigation can provide reference for the 
laboratory setting critical value reporting time-
frame and working out good quality practices. 
However, there were several limitations. Firstly, as 
recognition time can barely be recorded in LIS, 
critical value reporting time in this survey refers to 
time from result validation to result communica-
tion to clinician which did not contain time from 
recognition to validation. Monitoring time from 
critical value recognition to validation was encour-
aged in laboratory if possible. Secondly, the major 
participants were from tertiary hospitals in China, 
so the results represent laboratories with more 
critical values and heavier workload in China. Ad-
ditionally, although it was a voluntary, free of 
charge and non-punitive investigation and labora-
tories were encouraged to submit truthful data, 
the truthfulness of data submitted by participants 
in this survey may still be questioned. Besides, rea-
sons submitted by participants for unreported 
critical value depending on number of laborato-
ries provided that answer. Finally, this is a short-
time survey and the data was collected only for 
one month, thus the robustness of error rates and 
sigma values we calculated was uncertain. Labora-
tories were advised to strengthen the construction 
of information systems to monitor critical value re-
porting process, set suitable timeframe and iden-
tify reasons for critical value reporting delay 
through lengthways internal monitoring and 
transverse external comparison. 
In conclusion, the majority of laboratories can re-
port critical values to responsible clinical staff 
within 25 minutes. Thus, in order to improve re-
porting of critical results of biochemistry analyses 
in most laboratories in China this value could be 
recommended as suitable reporting timeframe. 
However, along with timeframe setup, careful 
monitoring of the complete reporting process and 
improvement of the information systems could 
significantly contribute to timeliness in critical val-
ue reporting. 
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